A case of lung adenocarcinoma presenting with leptomeningeal carcinomatosis successfully treated with afati-nib after erlotinib-lnduced hepatotoxicity

Medicine and Dentistry

• Liver Toxicity 100%
• Lung Adenocarcinoma 100%
• Meningeal Carcinomatosis 100%
• Erlotinib 100%
• Afatinib 100%
• Overall Survival 33%
• Central Nervous System 33%
• Bevacizumab 33%
• Magnetic Resonance Imaging 33%
• Progression Free Survival 33%
• Disease Course 33%
• Epidermal Growth Factor Receptor 33%
• Lung Cancer 33%
• Monotherapy 33%
• Melena 33%
• Liver Enzyme 33%
• Cerebrospinal Fluid Cytology 33%

Keyphrases

• Erlotinib 100%
• Lung Adenocarcinoma 100%
• Hepatotoxicity 100%
• Leptomeningeal Carcinomatosis 100%
• Afatinib 100%
• Older Men 33%
• Overall Survival 33%
• Magnetic Resonance Imaging 33%
• Progression-free Survival 33%
• Clinical Course 33%
• Bevacizumab 33%
• Liver Enzymes 33%
• Melena 33%
• Monotherapy 33%
• Central Nervous System Lesions 33%
• EGFR-mutant Lung Cancer 33%
• Cerebrospinal Fluid Cytology 33%